Pure IDO play (almost, they have an ebola program) NLNK - which I nearly put in my charity portfolio - up 18% on no company specific news (don't think they're at JPM today). Coattailing on INCY? They have two P1 combo trials with PD-1 inhibitors.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.